| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 395.74M | 328.58M | 303.53M | 324.52M | 373.47M |
| Gross Profit | 117.54M | 94.41M | 86.43M | 79.39M | 79.92M |
| EBITDA | 59.34M | 38.59M | 28.28M | 34.59M | 37.27M |
| Net Income | 31.19M | 25.80M | 15.75M | 18.51M | 13.69M |
Balance Sheet | |||||
| Total Assets | 541.91M | 495.98M | 454.85M | 661.83M | 727.73M |
| Cash, Cash Equivalents and Short-Term Investments | 106.59M | 61.01M | 46.72M | 21.05M | 19.31M |
| Total Debt | 0.00 | 47.00K | 501.00K | 22.85M | 74.90M |
| Total Liabilities | 85.40M | 64.33M | 45.33M | 95.73M | 158.68M |
| Stockholders Equity | 456.51M | 431.65M | 409.52M | 566.11M | 569.06M |
Cash Flow | |||||
| Free Cash Flow | 52.45M | 16.35M | 54.27M | 58.24M | -32.31M |
| Operating Cash Flow | 54.80M | 21.66M | 58.53M | 59.92M | -23.10M |
| Investing Cash Flow | 8.04M | -3.04M | -11.30M | -1.62M | -8.40M |
| Financing Cash Flow | -9.99M | -4.38M | -29.19M | -56.03M | 28.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$2.08T | 28.13 | 22.82% | 0.21% | 5.28% | ― | |
74 Outperform | HK$1.43B | -2.34 | 8.98% | 6.40% | 13.14% | -28.26% | |
72 Outperform | HK$163.15M | 5.10 | 6.90% | 6.49% | 25.46% | 68.29% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | HK$65.97B | 27.82 | 2.28% | ― | 16.36% | 102.93% | |
48 Neutral | HK$471.32M | -7.70 | -16.83% | ― | -28.40% | -350.00% | |
40 Underperform | HK$727.43M | 22.18 | -4.59% | ― | >-0.01% | 98.32% |